MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Acquired by Northern Trust Corp

Northern Trust Corp raised its holdings in MeiraGTx Holdings plc (NASDAQ:MGTX - Free Report) by 18.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 315,665 shares of the company's stock after purchasing an additional 50,267 shares during the period. Northern Trust Corp owned 0.40% of MeiraGTx worth $1,922,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. Geode Capital Management LLC raised its position in shares of MeiraGTx by 16.4% in the fourth quarter. Geode Capital Management LLC now owns 570,646 shares of the company's stock valued at $3,475,000 after buying an additional 80,407 shares during the last quarter. Privium Fund Management B.V. raised its position in shares of MeiraGTx by 5.2% in the fourth quarter. Privium Fund Management B.V. now owns 225,078 shares of the company's stock valued at $1,371,000 after buying an additional 11,118 shares during the last quarter. Long Focus Capital Management LLC acquired a new position in shares of MeiraGTx in the fourth quarter valued at approximately $1,156,000. Charles Schwab Investment Management Inc. raised its position in shares of MeiraGTx by 13.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 112,021 shares of the company's stock valued at $682,000 after buying an additional 12,961 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of MeiraGTx by 10.6% in the fourth quarter. Bank of New York Mellon Corp now owns 106,582 shares of the company's stock valued at $649,000 after buying an additional 10,217 shares during the last quarter. Hedge funds and other institutional investors own 67.48% of the company's stock.

Insider Buying and Selling

In other news, CFO Richard Giroux sold 24,000 shares of the company's stock in a transaction on Tuesday, April 22nd. The shares were sold at an average price of $6.00, for a total value of $144,000.00. Following the completion of the transaction, the chief financial officer now directly owns 882,494 shares in the company, valued at approximately $5,294,964. This represents a 2.65% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Alexandria Forbes sold 47,500 shares of the company's stock in a transaction on Tuesday, April 8th. The shares were sold at an average price of $5.34, for a total transaction of $253,650.00. Following the completion of the transaction, the chief executive officer now owns 1,408,983 shares of the company's stock, valued at $7,523,969.22. This trade represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. 7.50% of the stock is currently owned by company insiders.

MeiraGTx Trading Up 5.1%

MGTX stock traded up $0.26 on Thursday, hitting $5.36. 340,916 shares of the company were exchanged, compared to its average volume of 363,889. MeiraGTx Holdings plc has a twelve month low of $3.85 and a twelve month high of $8.75. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34. The business's fifty day moving average is $5.91 and its two-hundred day moving average is $6.28. The stock has a market capitalization of $430.76 million, a price-to-earnings ratio of -4.43, a price-to-earnings-growth ratio of 0.37 and a beta of 1.30.

MeiraGTx (NASDAQ:MGTX - Get Free Report) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.13). MeiraGTx had a negative return on equity of 146.38% and a negative net margin of 633.05%. The company had revenue of $1.93 million for the quarter, compared to analyst estimates of $4.44 million. As a group, research analysts forecast that MeiraGTx Holdings plc will post -1.48 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on MGTX. Chardan Capital cut their price objective on shares of MeiraGTx from $38.00 to $35.00 and set a "buy" rating for the company in a research report on Wednesday, May 14th. Royal Bank of Canada boosted their price objective on shares of MeiraGTx from $11.00 to $13.00 and gave the company an "outperform" rating in a research report on Monday, March 17th. Finally, Wall Street Zen lowered shares of MeiraGTx from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.